Ann: BEYONDIE UPDATE - PROCESS DESIGN VALIDATED, page-100

As I indicated in an earlier post "the Company expects to be able to inform the market of the quantum of funding required by the end of June 2022." Should be very soon if they have sorted their production issues; or delayed maybe if they haven't sorted their production issues.

The SP is currently 6.7C. I think BioTrader is too high at 5.5c; I can't imagine investors opening their wallets for an 18% discount in this case unless it's accompanied by a very impressive announcement. COE's recent CR was about a 15% discount and COE is a much safer bet than KLL.

BioTrader, I lost $160K during the GFC and still get a knot in my stomach if I think about it. I sympathize at your loss. Best luck with your future endeavours.